Premium
Characterization of the in vivo and in vitro Effects of Indomethacin on Human Natural Killer Cell Activity
Author(s) -
Pedersen B. K.,
Oxholm P.,
Klarlund K.
Publication year - 1986
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/j.1398-9995.1986.tb00339.x
Subject(s) - in vivo , in vitro , pharmacology , cell , natural killer cell , monocyte , chemistry , prostaglandin , lymphokine activated killer cell , prostaglandin d2 , immunology , biology , biochemistry , cytotoxicity , interleukin 12 , cytotoxic t cell , microbiology and biotechnology
The in vivo and in vitro effects of indomethacin on the natural killer (NK) cell activity against K 562 target cells were studied In vivo administration of indomethacin, 3 × 50 mg for 7 days to normal donors did not influence baseline NK cell activity, which means that treatment with prostaglandin (PG) inhibitors can be allowed in studies on NK cell activity of persons with normal PG production. The NK cell activity of fresh mono‐nuclear cells was boosted with pharmacological concentrations of indomethacin in vitro , while frozen cells were not. Our results indicate that indomethacin enhances the NK cell activity in vitro by blocking the prostaglandin production of monocytes, since monocyte depleted effector cells were not boosted by indomethacin.